Gene expression signatures for HOXA4, HOXA9, and HOXD10 reveal alterations in transcriptional regulatory networks in colon cancer.


Journal

Journal of cellular physiology
ISSN: 1097-4652
Titre abrégé: J Cell Physiol
Pays: United States
ID NLM: 0050222

Informations de publication

Date de publication:
08 2019
Historique:
revised: 18 11 2018
accepted: 19 11 2018
pubmed: 16 12 2018
medline: 10 5 2020
entrez: 16 12 2018
Statut: ppublish

Résumé

We previously reported that HOXA4, HOXA9, and HOXD10 are selectively expressed in colonic stem cells (SCs) and their overexpression contributes to colorectal cancer (CRC). Our goals here were to determine how these HOX genes are transcriptionally regulated and whether transcriptional dysregulation of HOX genes occurs in CRC. Accordingly, we used correlation analysis to identify genes that are expression-correlated or anticorrelated with HOXA4, HOXA9, and HOXD10. We then used Gene Ontology (GO) analysis to functionally classify these genes. The GO results for both HOXA4 and HOXD10 correlated gene sets for normal colon and CRC show functions mostly classified as developmental, transcriptional regulation, and DNA binding. This raised the question: Are these gene sets regulated by the same transcription factors (TFs)? Consequently, we used promoter analysis and interaction network toolset (PAINT) to identify commonly shared transcription response elements. The results indicated that completely different sets of TFs coregulate HOXA4 and HOXD10 (but not HOXA9) and their expression-correlated genes. And predicted TFs are altered in CRC compared with normal colon. Taken together, analysis of gene signatures correlated with expression of HOXA4 and HOXD10 indicates how these HOX genes are: (a) transcriptionally regulated in the normal colon; (b) dysregulated in CRC. This discovery provides a mechanism for targeting CRC SCs.

Identifiants

pubmed: 30552679
doi: 10.1002/jcp.27975
doi:

Substances chimiques

Homeodomain Proteins 0
Transcription Factors 0
homeobox protein HOXA9 0
HOXA4 protein, human 127609-92-1
HOXD10 protein, human 145420-66-2

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

13042-13056

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

Seema Bhatlekar (S)

Center for Translational Cancer Research, Helen F. Graham Cancer Center and Research Institute, Newark, Delaware.
Department of Biological Sciences, University of Delaware, Newark, Delaware.

Adam Ertel (A)

Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.

Gregory E Gonye (GE)

Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Nanostring Technologies, Seattle, Washington.

Jeremy Z Fields (JZ)

CA*TX Inc, Princeton, New Jersey.

Bruce M Boman (BM)

Center for Translational Cancer Research, Helen F. Graham Cancer Center and Research Institute, Newark, Delaware.
Department of Biological Sciences, University of Delaware, Newark, Delaware.
Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH